AbbVie Buys Drugmaker Shire for $54 Billion

Shire Pharmaceuticals has accepted a $54-billion takeover bid from AbbVie in a deal aimed at slashing the U.S. giant's tax bill. read more
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.